4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-106269
Director sold 129,672 shares at $19.52 ($2,530,562)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kersten Dirk · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-11 | Sale : show line 1 in the form 10b5-1 | −129,672 | $19.52 | $2,530,562 | 4,644,386 | I |
| Open-market sales · 129,672 sh · avg $19.52 · $2,530,562 | ||||||
Loading xslF345X05/ownership.xml…